IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment
Cancer Cell, ISSN: 1535-6108, Vol: 41, Issue: 2, Page: 323-339.e10
2023
- 33Citations
- 35Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations33
- Citation Indexes33
- 33
- CrossRef16
- Captures35
- Readers35
- 35
Article Description
Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell lymphoma that originates from T follicular helper (Tfh) cells and exhibits a prominent tumor microenvironment (TME). IDH2 and TET2 mutations co-occur frequently in AITL, but their contribution to tumorigenesis is poorly understood. We developed an AITL mouse model that is driven by Idh2 and Tet2 mutations. Malignant Tfh cells display aberrant transcriptomic and epigenetic programs that impair TCR signaling. Neoplastic Tfh cells bearing combined Idh2 and Tet2 mutations show altered cross-talk with germinal center B cells that promotes B cell clonal expansion while decreasing Fas-FasL interaction and reducing B cell apoptosis. The plasma cell count and angiogenesis are also increased in the Idh2 -mutated tumors, implying a major relationship between Idh2 mutation and the characteristic AITL TME. Our mouse model recapitulates several features of human IDH2 -mutated AITL and provides a rationale for exploring therapeutic targeting of Tfh-TME cross-talk for AITL patients.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S153561082300003X; http://dx.doi.org/10.1016/j.ccell.2023.01.003; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85147560106&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36736318; https://linkinghub.elsevier.com/retrieve/pii/S153561082300003X; https://dx.doi.org/10.1016/j.ccell.2023.01.003; https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00003-X#.Y-fejpObDBg.twitter; http://www.cell.com/article/S153561082300003X/abstract; http://www.cell.com/article/S153561082300003X/fulltext; http://www.cell.com/article/S153561082300003X/pdf; https://www.cell.com/cancer-cell/abstract/S1535-6108(23)00003-X; https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00003-X?rss=yes&utm_source=dlvr.it&utm_medium=twitter; https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00003-X; https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00003-X?dgcid=raven_jbs_etoc_email; https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00003-X#.Y9v41-wq_cU.twitter; https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00003-X#.Y9w5b5brMmo.twitter; https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00003-X?rss=yes&utm_source=dlvr.it&utm_medium=twitter#.Y-4j3H6OSDo.twitter; https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00003-X?rss=yes&utm_source=dlvr.it&utm_medium=twitter#.Y9xBgKYfqz4.twitter
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know